Recommended therapies for restenosis

Author： Chopra A.   Strzelecki K.L.   Reese K.D.  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.9, Iss.4, 1999-04, pp. : 417-429

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug-eluting stents beat other therapies for in-stent restenosis

By  

Inpharma, Vol. 1, Iss. 1577, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

"There are gaps and significant variation" in the use of evidence-based, guideline-recommended therapies in patients with heart failure

By  

Inpharma, Vol. 1, Iss. 1608, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Increasing adherence to guideline-recommended therapies is associated with decreased mortality in patients aged ≥ 90 years with acute coronary syndromes

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 530, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

The EMEA's CHMP has recommended the contraindication of certain erectile dysfunction therapies in patients with single-eye vision loss

By  

Reactions Weekly, Vol. 1, Iss. 1102, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Extent of Control of Cardiovascular Risk Factors and Adherence to Recommended Therapies in US Multiethnic Adults with Coronary Heart Disease: From a 2005-2006 National Survey

By Vulic Dusko  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 2, 2010-04 ,pp. : 109-114

Adis International

Access to resources Recommend Favorite